Aclarity Raises $16M in Series A Funding

Aclarity
The Aclarity team pictured with their Mobile Field Deployment PFAS destruction unit.

Aclarity, Inc., a Mansfield, MA-based leader in PFAS (Per- and Polyfluoroalkyl Substances) “forever chemical” destruction, closed its $15.9m Series A funding round.

The round was led by Aqualateral, with participation from HG Ventures, Bidra Innovation Ventures, Nor’easter Ventures, MassVentures, and Burnt Island Ventures.

The company intends to use the funds to enter into a new phase of commercial expansion and innovation.

Led by Julie Bliss Mullen, Founder and CEO, Aclarity is working for the elimination of persistent and hazardous “forever chemicals” known as PFAS, which accumulate in human and animal tissues and persist indefinitely in the environment. Its Octa™ PFAS destruction systems employ proprietary technology to fight against the ongoing PFAS contamination cycle. The conventional approach for removing and disposing of PFAS has led to concentrated PFAS materials being reintroduced into the environment through methods like landfill disposal, incineration, and deep well disposal, recontaminating the air, soil, and water.

The technology employs electricity to sever the carbon and fluorine bonds that give PFAS compounds their durability, thus putting an end to the perpetual PFAS contamination cycle.

FinSMEs

02/11/2023